Nitric Oxide to improve recovery and survival in neonates and children on Extracorporeal Life Support - a pilot randomized controlled trial (the NECTAR trial) (2019–2022)

Grant type:
The Children's Hospital Foundation
Researchers:
Funded by:
The Children's Hospital Foundation